Literature DB >> 8818442

Dose-dependent appearance and disappearance of amiodarone-induced skin pigmentation.

N G Kounis1, C Frangides, P J Papadaki, G M Zavras, J Goudevenos.   

Abstract

A 66-year-old man suffering from atrial flutter developed cutaneous blue-gray pigmentation while receiving 600 mg of amiodarone daily for 15 months. With reduction of the dose to 100 mg, skin discoloration disappeared within 16 months, to reappear within 7 months after increasing the dose to 400 mg. Finally, the discoloration disappeared within 13 months with a dose reduction to 200 mg daily. It seems that a tissue threshold level for amiodarone exists in this patient, above which skin discoloration appears and below which it fades. Dose, duration, metabolism, macrophage transfer, and spillover saturation-excretion may be relevant in amiodarone-induced skin pigmentation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8818442     DOI: 10.1002/clc.4960190713

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  4 in total

1.  [Hyperpigmentation of the face].

Authors:  J Dissemond; T Franckson; G Fitz; U Hillen; M Goos
Journal:  Hautarzt       Date:  2003-08-21       Impact factor: 0.751

2.  Blue man syndrome.

Authors:  Umjeet Jolly; George Klein
Journal:  CMAJ       Date:  2016-02-08       Impact factor: 8.262

Review 3.  [Clinical aspects of treatment with amiodarone].

Authors:  W Haverkamp; C Israel; A Parwani
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-09

4.  A Physiologically Based Pharmacokinetic Model of Amiodarone and its Metabolite Desethylamiodarone in Rats: Pooled Analysis of Published Data.

Authors:  Jing-Tao Lu; Ying Cai; Feng Chen; Wei-Wei Jia; Zhe-Yi Hu; Yuan-Sheng Zhao
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.